Abstract:Background: Recruitment and entrapment of bone marrow-derived endothelial progenitor cells (EPCs) is important in vascular endothelial growth factor (V-EGF)-induced angiogenesis. EPC mobilization and differentiation are modulated by stromal-derived factor-1 alpha (SDF-1 alpha/CXCL12), another important chemokine. In this study, we investigated the hypothesis that SDF-1 alpha and VEGF might act synergistically on EPC-mediated vasculogenesis.Methods: EPCs were isolated and cultured from human peripheral blood, then transduced with retroviral vectors pBabe containing human VEGF(165) complimentary DNA (Td/V-EPCs) and pBabe wild-type (Td/p-EPCs). EPC migration activity was investigated with a modified Boyden chamber assay. EPC apoptosis induced by serum starvation was studied by annexin V assays. The combined effect of local administration of SDF-1 alpha and Td/V-EPC transplantation on neovascularization was investigated in a murine model of hind limb ischemia.Results. Over-expression of hV-EGF(165) increased SDF-1 alpha-mediated EPC migration. SDF-1 alpha-mediated migration was significantly increased when EPCs were modified with VEGF (Td/V-EPCs) vs when VEGF was not present (Td/p-EPCs) or when VEGF alone was present (Td/V-EPCs; 196.8 +/- 15.2, 81.2 +/- 9.8, and 67.4 +/- 7.4/mm(2), respectively P < .001). SDF-1 alpha combined with VEGF reduced serum starvation-induced apoptosis of EPCs more than SDF-1 alpha or VEGF alone (P < .001). To determine the effect of this combination in vivo, SDF-1 alpha was locally injected alone into the ischemic hind limb muscle of nude mice or combined with systemically injected Td/V-EPCs. The SDF-1 alpha plus VEGF group showed significantly increased local accumulation of EPCs, blood-flow recovery, and capillary density compared with the other groups. The ratio of ischemic/normal blood flow in Td/V-EPCs plus SDF-1 alpha group was significantly higher (P < .01), as was capillary density (capillaries/mm(2)), an index of neovascularization (Td/V-EPCs plus SDF-1 alpha group, 863 31; no treatment, 395 +/- 13; SDF-1 alpha, 520 +/- 29; Td/p-EPCs, 448 +/- 28; Td/p-EPCs plus SDF-1 alpha., 620 +/- 29; Td/V-EPCs, 570 +/- 30; P < .01). To investigate a possible mechanistic basis, we showed that VEGF up-regulated the receptor for SDF-1 alpha, CXCR4, on EM in Nitro.Conclusion: The combination of SDF-1 alpha and VEGF greatly increases EPC-mediated angiogenesis. The use VEGF and SDF-1 alpha together, rather than alone, will be a novel and efficient angiogenesis strategy to provide therapeutic neovascularization. (J Vase Surg 2009;50:608-16.)

AMD3100 Mobilizes Endothelial Progenitor Cells in Mice, but Inhibits Its Biological Functions by Blocking an Autocrine/Paracrine Regulatory Loop of Stromal Cell Derived Factor-1 in Vitro

Effect of AMD3100 on SDF-1 induced proliferation and migration of endothelial progenitor cells

The Effect of Amd3100 on the Proliferation, Migration and Adhesion of Apoe(-/-) Mice Bone Marrow Endothelial Progenitor Cells

Stromal Cell‐derived Factor 1α Reduces Senescence of Endothelial Progenitor Subpopulation in Lectin‐binding and DiLDL‐uptaking Cell Through Telomerase Activation and Telomere Elongation

Sustained Release of Stromal Cell-Derived Factor-1α from Injectable Hydrogels in Combination with Endothelial Progenitor Cells Effectively Promotes Neovascularization in Ischemic Diabetic Rats

Interruption of CD40 Pathway Improves Efficacy of Transplanted Endothelial Progenitor Cells in Monocrotaline Induced Pulmonary Arterial Hypertension.

Combination of granulocyte colony-stimulating factor and CXCR4 antagonist AMD3100 for effective harvest of endothelial progenitor cells from peripheral blood and in vitro formation of primitive endothelial networks

Effect of AMD3100 on the Proliferation and Angiogenesis of AsPC-1 Cells

[Some Research Progress of CXCR4 Antagonist AMD3100].

Selective Enhancement of Donor Hematopoietic Cell Engraftment by the CXCR4 Antagonist AMD3100 in a Mouse Transplantation Model

CXCR4 Antagonist AMD3100 Promotes Mesenchymal Stem Cell Mobilization in Rats Preconditioned with the Hypoxia-Mimicking Agent Cobalt Chloride

Involvement of Stromal Cell-Derived Factor-1-CXCR4 Axis in Recruitment of Endothelial Progenitor Cell and Reendotheliazation After Vascular Injury in Mice

3-Amino-4-(3-hexylphenylamino)-4-oxobutyl Phosphonic Acid (W146), a Selective Antagonist of Sphingosine-1-phospahte Receptor Subtype 1, Enhances AMD3100-stimulated Mobilization of Hematopoietic Stem Progenitor Cells in Animals.

AMD3100 Inhibits Epithelial–mesenchymal Transition, Cell Invasion, and Metastasis in the Liver and the Lung Through Blocking the SDF‐1α/CXCR4 Signaling Pathway in Prostate Cancer

Combination of Stromal-Derived Factor-1Α and Vascular Endothelial Growth Factor Gene-Modified Endothelial Progenitor Cells is More Effective for Ischemic Neovascularization

AMD3100 Inhibits the Migration and Differentiation of Neural Stem Cells after Spinal Cord Injury

SDF-1 Combined with Peripheral Blood Endothelial Progenitor Cells Transplantation for the Treatment of Hindlimb Ischemia in Nude Mice

AMD3100 imposes blockade on CXCR4~+ regulatory T cell migration

Cxcr4 Antagonist Delivery On Decellularized Skin Scaffold Facilitates Impaired Wound Healing In Diabetic Mice By Increasing Expression Of Sdf-1 And Enhancing Migration Of Cxcr4-Positive Cells

Effects of rapamycin on number and activity of endothelial progenitor cells

SDF-1α/CXCR4 Decreases Endothelial Progenitor Cells Apoptosis under Serum Deprivation by PI3K/Akt/eNOS Pathway